1gOgRTa

1 2 3 4 5 6 7 8Why a toolkit?The right time The right insulin Mythsand barriersInsulin management:key factsCommissioning forpeople with Type 2diabetesMedicinesoptimisationteamsCommunitypharmacy9AcknowledgementsThis toolkit was informed by arepresentative group of serviceusers, medicines optimisation teams,commissioners, academic colleaguesand providers who have generouslycontributed resources and sharedtheir experiences and expertise withthe Health Innovation Network to helpsupport change in South London.Why a toolkit?We have known for some time how to effectivelytreat Type 2 diabetes and how to achieve goodglycaemic control using lifestyle interventionsand timely use of therapeutic agents.Unfortunately, despite this knowledge, largenumbers of people fail to achieve personalisedoptimal control. In addition there are largeinequalities across different care settings andbetween populations. This puts many people athigher risk of diabetes-related complications andcan be demoralising for healthcare professionals.There are many underlying reasons for this failurewhich this toolkit seeks to address.The toolkit provides a background to theimportance of early and appropriate medicationintensification and use of the Right Insulin at theRight Time at the Right Dose. It exposes the mythsabout insulin therapy and considers why, for thevast majority of people, human intermediate actinginsulins are preferable for initiation compared tolong and intermediate acting analogue insulins.The toolkit also explores what can go wrong inthe intensification pathway and suggests waysin which this could be improved.Who is the toolkit for?• Healthcare professionals in primarycare and secondary care• Commissioners• Medicines Optimisation Teams• Community PharmacistsUsing the toolkitLinks to useful resources can be found withinthe toolkit. These include exemplar prescribingguidance, audits, evidence reviews, responsibleprescribing messages, useful case studies andexamples of good practice.A number of our resources are from within ourlocal network where colleagues have agreed toshare best practice. The resources offer a menuof options for you to tap into to support patientswith early and appropriate dose escalation andinsulin management to optimise glycaemicoutcomes in a clinical and cost effective way.Although this toolkit focuses on optimisationof glycaemic control, it is important not to forgetthe importance of reducing cardiovascular risk toimprove outcomes for people with Type 2 diabetes 1,2 .Back to contentsReferencesRight Insulin, Right Time, Right Dose 4